Related references
Note: Only part of the references are listed.Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy
Alvin Kamili et al.
BRITISH JOURNAL OF CANCER (2020)
Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma
Laura D. Gamble et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding Interface
Jessica Koach et al.
CANCER RESEARCH (2019)
In Vivo Modeling of Chemoresistant Neuroblastoma Provides New Insights into Chemorefractory Disease and Metastasis
Orli Yogev et al.
CANCER RESEARCH (2019)
Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design
Jo Lynne Rokita et al.
CELL REPORTS (2019)
Activated Natural Killer Cells in Combination with Anti-GD2 Antibody Dinutuximab Improve Survival of Mice after Surgical Resection of Primary Neuroblastoma
Wesley E. Barry et al.
CLINICAL CANCER RESEARCH (2019)
The landscape of genomic alterations across childhood cancers
Susanne N. Groebner et al.
NATURE (2018)
Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours
Xiaotu Ma et al.
NATURE (2018)
A reliable murine model of bone metastasis by injecting cancer cells through caudal arteries
Takahiro Kuchimaru et al.
NATURE COMMUNICATIONS (2018)
Patient-derived xenografts as preclinical neuroblastoma models
Noemie Braekeveldt et al.
CELL AND TISSUE RESEARCH (2018)
A Metastatic Mouse Model Identifies Genes That Regulate Neuroblastoma Metastasis
Bo Kyung A. Seong et al.
CANCER RESEARCH (2017)
Patient-derived xenografts for childhood solid tumors: a valuable tool to test new drugs and personalize treatments
P. Zarzosa et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2017)
Suppression of the ATP-binding cassette transporter ABCC4 impairs neuroblastoma tumour growth and sensitises to irinotecan in vivo
Jayne Murray et al.
EUROPEAN JOURNAL OF CANCER (2017)
Orthotopic patient-derived xenografts of paediatric solid tumours
Elizabeth Stewart et al.
NATURE (2017)
The mutational landscape of MYCN, Lin28b and ALKF1174L driven murine neuroblastoma mimics human disease
Bram De Wilde et al.
Oncotarget (2017)
PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models
Terrence F. Meehan et al.
CANCER RESEARCH (2017)
Impact of Disseminated Neuroblastoma Cells on the Identification of the Relapse-Seeding Clone
M. Reza Abbasi et al.
CLINICAL CANCER RESEARCH (2017)
Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor Spectra
Juliann Chmielecki et al.
CANCER RESEARCH (2017)
Intramuscular Transplantation Improves Engraftment Rates for Esophageal Patient-Derived Tumor Xenografts
Matthew Read et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Crizotinib Synergizes with Chemotherapy in Preclinical Models of Neuroblastoma
Kateryna Krytska et al.
CLINICAL CANCER RESEARCH (2016)
The ALK/ROS1 Inhibitor PF-06463922 Overcomes Primary Resistance to Crizotinib in ALK-Driven Neuroblastoma
Nicole R. Infarinato et al.
CANCER DISCOVERY (2016)
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice
Elizabeth C. Townsend et al.
CANCER CELL (2016)
Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumours
Noemie Braekeveldt et al.
CANCER LETTERS (2016)
p53 Loss in MYC-Driven Neuroblastoma Leads to Metabolic Adaptations Supporting Radioresistance
Orli Yogev et al.
CANCER RESEARCH (2016)
Evaluation of Alternative In Vivo Drug Screening Methodology: A Single Mouse Analysis
Brendan Murphy et al.
CANCER RESEARCH (2016)
Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression
Nicholas F. Evageliou et al.
CLINICAL CANCER RESEARCH (2016)
Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma
Yumeng Mao et al.
CLINICAL CANCER RESEARCH (2016)
The Childhood Solid Tumor Network: A new resource for the developmental biology and oncology research communities
Elizabeth Stewart et al.
DEVELOPMENTAL BIOLOGY (2016)
Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A study from the International Neuroblastoma Risk Group database
Daniel A. Morgenstern et al.
EUROPEAN JOURNAL OF CANCER (2016)
Long term, continuous exposure to panobinostat induces terminal differentiation and long term survival in the TH-MYCN neuroblastoma mouse model
Kelly Waldeck et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
A novel minimal residual disease model of neuroblastoma in mice
Jeremy R. Jackson et al.
JOURNAL OF PEDIATRIC SURGERY (2016)
ALKR1275Q perturbs extracellular matrix, enhances cell invasion and leads to the development of neuroblastoma in cooperation with MYCN
T. Ueda et al.
ONCOGENE (2016)
Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome
Olivia M. Padovan-Merhar et al.
PLOS GENETICS (2016)
Labeling of Breast Cancer Patient-derived Xenografts with Traceable Reporters for Tumor Growth and Metastasis Studies
Colton Hanna et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2016)
Anti-GD2 mAb and Vorinostat synergize in the treatment of neuroblastoma
Michiel Kroesen et al.
ONCOIMMUNOLOGY (2016)
Neuroblastoma
Katherine K. Matthay et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
PI3K-mTORC2 but not PI3K-mTORC1 Regulates Transcription of HIF2A/EPAS1 and Vascularization in Neuroblastoma
Sofie Mohlin et al.
CANCER RESEARCH (2015)
Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma
M. Emmy M. Dolman et al.
CLINICAL CANCER RESEARCH (2015)
Development and characterization of a human orthotopic neuroblastoma xenograft
Elizabeth Stewart et al.
DEVELOPMENTAL BIOLOGY (2015)
Establishment of a patient-derived orthotopic osteosarcoma mouse model
Claudia Blattmann et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
Thomas F. Eleveld et al.
NATURE GENETICS (2015)
The CXCR4/CXCR7/CXCL12 Axis Is Involved in a Secondary but Complex Control of Neuroblastoma Metastatic Cell Homing
Annick Muehlethaler-Mottet et al.
PLOS ONE (2015)
Early Development of Human Lymphomas in a Prostate Cancer Xenograft Program Using Triple Knock-Out Immunocompromised Mice
Christian Wetterauer et al.
PROSTATE (2015)
Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma
Daniel R. Carter et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
The extent of inflammatory infiltration in primary cancer tissues is associated with lymphomagenesis in immunodeficient mice
Lianhai Zhang et al.
SCIENTIFIC REPORTS (2015)
Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors
Gennadiy Bondarenko et al.
NEOPLASIA (2015)
Neuroblastoma models for insights into tumorigenesis and new therapies
Shinichi Kiyonari et al.
EXPERT OPINION ON DRUG DISCOVERY (2015)
Neuroblastoma patient-derived orthotopic xenografts retain metastatic patterns and geno- and phenotypes of patient tumours
Noemie Braekeveldt et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies
K. Althoff et al.
ONCOGENE (2015)
FAK is a critical regulator of neuroblastoma liver metastasis
Sora Lee et al.
Oncotarget (2015)
ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma
Scott C. Bresler et al.
CANCER CELL (2014)
A transplantable TH-MYCN transgenic tumor model in C57Bl/6 mice for preclinical immunological studies in neuroblastoma
Michiel Kroesen et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Emergence of New ALK Mutations at Relapse of Neuroblastoma
Gudrun Schleiermacher et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
An unexpected role for caspase-2 in neuroblastoma
L. Dorstyn et al.
CELL DEATH & DISEASE (2014)
Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
Manuel Hidalgo et al.
CANCER DISCOVERY (2014)
NCYM, a Cis-Antisense Gene of MYCN, Encodes a De Novo Evolved Protein That Inhibits GSK3β Resulting in the Stabilization of MYCN in Human Neuroblastomas
Yusuke Suenaga et al.
PLOS GENETICS (2014)
The prenatal origins of cancer
Glenn M. Marshall et al.
NATURE REVIEWS CANCER (2014)
Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma
Markus Brockmann et al.
CANCER CELL (2013)
Midkine Promotes Neuroblastoma through Notch2 Signaling
Satoshi Kishida et al.
CANCER RESEARCH (2013)
Th-MYCN Mice with Caspase-8 Deficiency Develop Advanced Neuroblastoma with Bone Marrow Metastasis
Tal Teitz et al.
CANCER RESEARCH (2013)
Molecular Imaging of Neuroblastoma Progression in TH-MYCN Transgenic Mice
Carmelo Quarta et al.
MOLECULAR IMAGING AND BIOLOGY (2013)
The genetic landscape of high-risk neuroblastoma
Trevor J. Pugh et al.
NATURE GENETICS (2013)
Xenograft Tumors Vascularized with Murine Blood Vessels May Overestimate the Effect of Anti-Tumor Drugs: A Pilot Study
Zhihong Dong et al.
PLOS ONE (2013)
Evaluation of Clinically Translatable MR Imaging Biomarkers of Therapeutic Response in the TH-MYCN Transgenic Mouse Model of Neuroblastoma
Yann Jamin et al.
RADIOLOGY (2013)
Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition
Alexandre Puissant et al.
CANCER DISCOVERY (2013)
The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma
Teeara Berry et al.
CANCER CELL (2012)
Establishment and characterization of xenograft models of human neuroblastoma bone metastasis
Hongyu Zhao et al.
CHILDS NERVOUS SYSTEM (2012)
Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue
David J. Monsma et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma
Sharon J. Diskin et al.
NATURE GENETICS (2012)
LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression
Jan J. Molenaar et al.
NATURE GENETICS (2012)
Patient-derived tumour xenografts as models for oncology drug development
John J. Tentler et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
The secret ally: immunostimulation by anticancer drugs
Lorenzo Galluzzi et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Tumor Development, Growth Characteristics and Spectrum of Genetic Aberrations in the TH-MYCN Mouse Model of Neuroblastoma
Agnes Rasmuson et al.
PLOS ONE (2012)
Targeted Expression of Mutated ALK Induces Neuroblastoma in Transgenic Mice
Lukas C. Heukamp et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma
J. Buechner et al.
BRITISH JOURNAL OF CANCER (2011)
ABCC Multidrug Transporters in Childhood Neuroblastoma: Clinical and Biological Effects Independent of Cytotoxic Drug Efflux
Michelle J. Henderson et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
The Aurora Kinase Inhibitor CCT137690 Downregulates MYCN and Sensitizes MYCN-Amplified Neuroblastoma In Vivo
Amir Faisal et al.
MOLECULAR CANCER THERAPEUTICS (2011)
A Pilot Clinical Study of Treatment Guided by Personalized Tumorgrafts in Patients with Advanced Cancer
Manuel Hidalgo et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Hypermethylation of Apoptotic Genes as independent Prognostic Factor in Neuroblastoma Disease
Elena Grau et al.
MOLECULAR CARCINOGENESIS (2011)
Preclinical Models for Neuroblastoma: Establishing a Baseline for Treatment
Tal Teitz et al.
PLOS ONE (2011)
Genetically engineered murine models - Contribution to our understanding of the genetics, molecular pathology and therapeutic targeting of neuroblastoma
Louis Chesler et al.
SEMINARS IN CANCER BIOLOGY (2011)
High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed Neuroblastoma
Jane Carr-Wilkinson et al.
CLINICAL CANCER RESEARCH (2010)
MYCN Promotes the Expansion of Phox2B-Positive Neuronal Progenitors to Drive Neuroblastoma Development
Goleeta Alam et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Small-Molecule Multidrug Resistance-Associated Protein 1 Inhibitor Reversan Increases the Therapeutic Index of Chemotherapy in Mouse Models of Neuroblastoma
Catherine A. Burkhart et al.
CANCER RESEARCH (2009)
A Primary Xenograft Model of Small-Cell Lung Cancer Reveals Irreversible Changes in Gene Expression Imposed by Culture In vitro
Vincent C. Daniel et al.
CANCER RESEARCH (2009)
Direct In Vivo Xenograft Tumor Model for Predicting Chemotherapeutic Drug Response in Cancer Patients
B. Rubio-Viqueira et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Clusterin, a Haploinsufficient Tumor Suppressor Gene in Neuroblastomas
Olesya Chayka et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Regression of orthotopic neuroblastoma in mice by targeting the endothelial and tumor cell compartments
Dieter Fuchs et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice
Michael P. Kim et al.
NATURE PROTOCOLS (2009)
Highly Sensitive Model for Xenogenic GVHD Using Severe Immunodeficient NOG Mice
Ryoji Ito et al.
TRANSPLANTATION (2009)
In Vivo Antitumor and Antimetastatic Activity of Sunitinib in Preclinical Neuroblastoma Mouse Model
Libo Zhang et al.
NEOPLASIA (2009)
Mdm2 Deficiency Suppresses MYCN-Driven Neuroblastoma Tumorigenesis In Vivo
Zaowen Chen et al.
NEOPLASIA (2009)
ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma
Michael D. Hogarty et al.
CANCER RESEARCH (2008)
Plasma midkine level is a prognostic factor for human neuroblastoma
Shinya Ikematsu et al.
CANCER SCIENCE (2008)
Identification of ALK as a major familial neuroblastoma predisposition gene
Yael P. Mosse et al.
NATURE (2008)
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
Isabelle Janoueix-Lerosey et al.
NATURE (2008)
Gastrin-releasing peptide receptor silencing suppresses the tumorigenesis and metastatic potential of neuroblastoma
Jingbo Qiao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Selective blockade of MicroRNA processing by Lin28
Srinivas R. Viswanathan et al.
SCIENCE (2008)
Chemotherapy-Induced Apoptosis in a Transgenic Model of Neuroblastoma Proceeds Through p53 Induction
Louis Chesler et al.
NEOPLASIA (2008)
The pediatric preclinical testing program: Description of models and early testing results
Peter J. Houghton et al.
PEDIATRIC BLOOD & CANCER (2007)
Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis
Tao Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma
Louis Chesler et al.
CANCER RESEARCH (2007)
In vivo bioluminescence imaging for early detection and monitoring of disease progression in a murine model of neurobtastoma
Paxton V. Dickson et al.
JOURNAL OF PEDIATRIC SURGERY (2007)
Murine models to evaluate novel and conventional therapeutic strategies for cancer
James E. Talmadge et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma
M Haber et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Potentiation of neuroblastoma metastasis by loss of caspase-8
DG Stupack et al.
NATURE (2006)
Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro
MD Norris et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Mechanisms of embryonal tumor initiation:: Distinct roles for MycN expression and MYCN amplification
LM Hansford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A fluorescent orthotopic mouse model for reliable measurement and genetic modulation of human neuroblastoma metastasis
KC Henriksson et al.
CLINICAL & EXPERIMENTAL METASTASIS (2004)
Pinhole imaging of 131I-metaiodobenzyl-guanidine (131-I-MIBG) in an animal model of neuroblastoma
R Accorsi et al.
PEDIATRIC RADIOLOGY (2003)
Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials
JI Johnson et al.
BRITISH JOURNAL OF CANCER (2001)
Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN
T Teitz et al.
NATURE MEDICINE (2000)
Share Paper
